Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Trends in therapeutic and prevention strategies for management of bovine mastitis: An overview

    192619_95459_75383.pdf (1.677Mb)
    Access Status
    Open access
    Authors
    Tiwari, J.G.
    Babra, C.
    Tiwari, H.
    Williams, Vincent
    De Wet, S.
    Gibson, J.
    Paxman, Adrian
    Morgan, Eleanor
    Costantino, Paul
    Sunagar, Raju
    Isloor, Shrikrishna
    Mukkur, Trilochan
    Date
    2013
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Tiwari, Jully Gogoi and Babra, Charlene and Tiwari, Harish Kumar and Williams, Vincent and de Wet, Sharon and Gibson, Justine and Paxman, Adrian and Morgan, Eleanor and Costantino, Paul and Sunagar, Raju and Isloor, Shrikrishna and Mukkur, Trilochan. 2013. Trends in therapeutic and prevention strategies for management of bovine mastitis: An overview. Journal of Vaccines & Vaccination. 4 (1): pp. 1-11.
    Source Title
    Journal of Vaccines & Vaccination
    DOI
    10.4172/2157-7560.1000176
    Additional URLs
    http://www.omicsonline.org/jvvhome.php
    ISSN
    2157-7560
    Remarks

    © 2013 Tiwari JG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    URI
    http://hdl.handle.net/20.500.11937/3515
    Collection
    • Curtin Research Publications
    Abstract

    Mastitis is one of the most economically significant diseases for the dairy industry for backyard farmers in developing countries and high producing herds worldwide. Two of the major factors impeding reduction in the incidence of this disease is [a] the lack of availability of an effective vaccine capable of protecting against multiple etiological agents and [b] propensity of some of the etiological agents to develop persistent antibiotic resistance in biofilms. This is further complicated by the continuing revolving shift in the predominant etiological agents of mastitis, depending upon a multitude of factors such as variability in hygienic practices on farms, easy access leading to overuse of appropriate or inappropriate antibiotics at suboptimal concentrations, particularly in developing countries, and lack of compliance with the recommended treatment schedules. Regardless, Staphylococcus aureusand Streptococcus uberis followed by Escherichia coli, Streptococcus agalactiae has become the predominant etiological agents of bovine mastitis followed Streptococcus agalactiae, Streptococcus dysagalactiae, Klebsiella pneumonia and the newly emerging Mycoplasma bovis. Current approaches being pursued to reduce the negative economic impact of this disease are through early diagnosis of infection, immediate treatment with an antibiotic found to either inhibit or kill the pathogen(s) in vitro using planktonic cultures and the use of the currently marketed vaccines regardless of their demonstrated effectiveness. Given the limitations of breeding programs, including genetic selection to improve resistance against infectious diseases including mastitis, it is imperative to have the availabilityof an effective broad-spectrum, preferably cross-protective, vaccine capable of protecting against bovine mastitis for reduction in the incidence of bovine mastitis, as well as interrupting the potential cross-species transmission to humans. This overview highlights the major etiological agents, factors affecting susceptibility to mastitis, and the current status of antibiotic-based therapies and prototype vaccine candidates or commercially available vaccines against bovine mastitis as potential preventative strategies.

    Related items

    Showing items related by title, author, creator and subject.

    • Mammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse Mastitis Model
      Gogoi Tiwari, Jully; Williams, Vincent; Waryah, Charlene; Costantino, Paul; Al-Salami, Hani; Mathavan, Sangeetha; Wells, Kelsi; Tiwari, H.; Hegde, N.; Isloor, S.; Al-Sallami, H.; Mukkur, Trilochan (2017)
      BACKGROUND: Biofilm formation by Staphylococcus aureus is an important virulence attribute because of its potential to induce persistent antibiotic resistance, retard phagocytosis and either attenuate or promote inflammation, ...
    • Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India
      Gogoi Tiwari, Jully; Babra Waryah, C.; Sunagar, R.; Veeresh, H.; Nuthanalakshmi, V.; Preethirani, P.; Sharada, R.; Isloor, S.; Bhat, A.; Al-Salami, Hani; Hegde, N.; Mukkur, T. (2015)
      Objective: To determine the prevalence of the different capsular polysaccharide (CP) and major surface-associated non-CP antigen 336 (SP-336) types among Staphylococcus aureus isolated from bovine mastitis cases in Australia ...
    • The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia
      Babra, C.; Gogoi Tiwari, Jully; Pier, G.; Thein, T.H.; Sunagar, R.; Sundareshan, S.; Isloor, S.; Hegde, N.; De Wet, S.; Deighton, M.; Gibson, J.; Costantino, Paul; Wetherall, John; Mukkur, Trilochan (2013)
      The aim of this investigation was to determine the persistence of biofilm-associated antibiotic resistance developed by methicillin-sensitive Staphylococcus aureus (MSSA), of different capsular types, during biofilm ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.